BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 17983675)

  • 1. Patent border wars: defining the boundary between scientific discoveries and patentable inventions.
    Holman CM
    Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
    Jakas J
    Seton Hall Law Rev; 2012; 42(3):1287-36. PubMed ID: 22803220
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent protection for Aspergillus-related inventions.
    Jong SC; Birmingham JM
    Biotechnology; 1992; 23():297-311. PubMed ID: 1504603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patents on life? No patent on life!].
    van Raden L
    Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 10. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 11. Roche faces charges over Taq patent claim.
    Abbott A
    Nature; 1996 Aug; 382(6593):660. PubMed ID: 8751427
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 13. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotech patents: the world is your oyster--or mouse--or (you name it).
    Alix JE
    Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
    Lu DL; Kowalski TJ; Jarecki-Black J
    Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
    [No Abstract]   [Full Text] [Related]  

  • 16. The burgeoning science of genetics and the impact on public policy.
    Hatch OG
    J Biolaw Bus; 2004; 7(4):3-6. PubMed ID: 15675088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontraditional publications and their effect on patentable inventions.
    Garabedian TE
    Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent law. Natural substances and patentable inventions.
    Demaine LJ; Fellmeth AX
    Science; 2003 May; 300(5624):1375-6. PubMed ID: 12775825
    [No Abstract]   [Full Text] [Related]  

  • 20. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.